Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.
Annals of the rheumatic diseases.
Times cited: 8
Inactive disease and remission in childhood-onset systemic lupus erythematosus.
Arthritis care & research.
Times cited: 11